| Literature DB >> 25984351 |
André F Maia1, Marvin E Tanenbaum2, Matilde Galli3, Daphne Lelieveld4, David A Egan4, Reto Gassmann5, Claudio E Sunkel5, Sander van den Heuvel3, René H Medema2.
Abstract
Kinesins are a superfamily of microtubule-based molecular motors that perform various transport needs and have essential roles in cell division. Among these, the kinesin-5 family has been shown to play a major role in the formation and maintenance of the bipolar mitotic spindle. Moreover, recent work suggests that kinesin-5 motors may have additional roles. In contrast to most model organisms, the sole kinesin-5 gene in Caenorhabditis elegans, bmk-1, is not required for successful mitosis and animals lacking bmk-1 are viable and fertile. To gain insight into factors that may act redundantly with BMK-1 in spindle assembly and to identify possible additional cellular pathways involving BMK-1, we performed a synthetic lethal screen using the bmk-1 deletion allele ok391. We successfully knocked down 82% of the C. elegans genome using RNAi and assayed viability in bmk-1(ok391) and wild type strains using an automated high-throughput approach based on fluorescence microscopy. The dataset includes a final list of 37 synthetic lethal interactions whose further study is likely to provide insight into kinesin-5 function.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25984351 PMCID: PMC4431526 DOI: 10.1038/sdata.2015.20
Source DB: PubMed Journal: Sci Data ISSN: 2052-4463 Impact factor: 6.444
Figure 1Experimental workflow.
(a) Example of a mosaic reconstruction of an imaged well of the screen. In the magnification of field 2, the white arrowhead shows the pharynx of a parent worm, blue arrowheads show pharynxes of progeny, and the orange arrowhead points to excluded objects. Scale bar is 150 μm. (b) Flowchart of screening protocol. The primary screen was done in two technical replicates. The secondary screen followed the same protocol as the primary screen but used three biological replicates with two technical replicates each.
Final hit list
|
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||
| Table summarizing the genes that genetically interact with the worm kinesin-5 and the observed developmental defects upon dsRNA treatment. Description of the abbreviations can be found at | |||||||||
| 1 | B08 | R06C7.10 | myo-1 | Gro | Gro | ||||
| 1 | B11 | F36H2 | F36H2.1 | tat-5 | Emb | Emb | |||
| 1 | C09 | C39E9+B0564 | C39E9.14 | dli-1 | Emb | Adl+Ste+Bag | Emb | Ste+Pvl | |
| 1 | C11 | F46A9+F30A10 | F46A9.4 | F46A9.5 | skr-2+skr-1 | Gro | Gro | ||
| 1 | D05 | W09C3+T03F1 | W09C3.6 | T03F1.5 | gsp-3+gsp-4 | Gro | Gro | ||
| 1 | D07 | W01A8 | W01A8.4 | nuo-6 | Lva | Lva | |||
| 1 | D11 | C17E4 | C17E4.5 | pabp-2 | Gro+Lva | Gro+Lva | |||
| 1 | E11 | C41G7+M01E11 | C41G7.2 | M01E11.6 | klp-16+klp-15 | Emb | Gro | Emb | Gro |
| 2 | B11 | T26E3 | T26E3.3 | par-6 | Emb | Ste | Emb | Ste | |
| 2 | E11 | T08B2 | T08B2.8 | T08B2.7 | mrpl-23+ech-1.2 | Gro | Gro | ||
| 3 | C04 | F26E4 | F26E4.8 | tba-1 | Emb | Emb | |||
| 3 | C10 | Y71F9AM | Y71F9AM.4 | Y71F9AM.7 | cogc-3+Y71F9AM.7 | Ste+Sck | Ste+Sck | ||
| 3 | F11 | F52C6+M7 | M7.1 | F52C6.12 | ubc-2(let-70)+F52C6.12 | Emb | no defect | Emb | no defect |
| 4 | E05 | F37C12 | F37C12.3 | F37C12.3 | Gro | Gro | |||
| 4 | E08 | B0285 | B0285.1 | cdtl-7 | Lva | Lva | |||
| 4 | F03 | T12G3 | T12G3.5 | mrpl-51 | Gro+Lva | Gro+Lva | |||
| 4 | H05 | B0280 | B0280.9 | B0280.9 | Gro+Ste+Sck | Gro+Ste+Sck | |||
| 5 | C11 | W09H1+several other | several his- genes | Emb | Emb | ||||
| 5 | F02 | F09E5 | F09E5.1 | pkc-3 | Emb | Emb | |||
| 5 | F08 | Y49E10+Y51H7C+ Y9D1A+Y46H3C+etc | Gro | Gro | |||||
| 6 | C03 | several | F54D5.11 | T01G5.8 | Emb | Gro+Rup | Emb | Gro+Rup+Pat | |
| 6 | C06 | F01F1 | F01F1.7 | ddx-23 | Emb | Lva | Emb | Lva | |
| 6 | C09 | F58A4 | F58A4.8 | tbg-1 | Emb | Ste+Pvl | Emb | ||
| 6 | D07 | Y43C5A | Y43C5A.6 | rad-51 | no defect | no defect | |||
| 7 | A10 | H06I04 | H06I04.3 | H06I04.3 | Gro | Gro+Ste | |||
| 7 | E09 | M04D8 | M04D8.6 | xbx-3 | no defect | ||||
| 7 | H04 | F42A8+C06C3 | C06C3.1 | mel-11 | Adl+Ste+Bag | Ste+Sck | |||
| 7 | H12 | E04A4 | E04A4.7 | cyc-2.1 | Gro | Lva | |||
| 8 | A02 | K08F11 | K08F11.4 | yars-1 | Gro | Gro+Lva | |||
| 9 | H10 | YAC Y38F2AL | Y38F2AL.4 | vha-3 | Lva | >Gro | |||
| 9 | H12 | Y6E2A | Y6E2A.9 | sfxn-1.3 | Gro+Lva | no defect | |||
| 11 | B02 | Y82E9BR | Y82E9B5.3 | Y82E9BR.3+Y82E9BR.27+Y82E9BR.30 | Gro | >Gro | |||
| 11 | B07 | F26H11 | F26H11.1 | kbp-3 (knl) | Emb | Ste | Emb | Ste+Adl+Gro+Pvl | |
| 11 | D03 | F11A3+C50F4 | F11A3.2 | F11A3.2 | Gro | Ste+Lva | |||
| 12 | H02 | T27B1 | T27B1.2 | ztf-19/pat-9 | Emb | Emb | Pat+Adl+Rup+Dpy | ||
| 12 | F04 | T27B1 | T27B1.2 | ztf-19/pat-9 | Emb | Ste+Sck | Emb | ||
| 13 | D05 | F25G6 | F25G6.2 | symk-1 | Emb | no defect | Emb | Gro+Sck+Adl | |
| 13 | H02 | F49C12 | F49C12.13 | vha-17 | Gro | ||||
Figure 2Genome-wide RNAi screen results.
(a, top) Determination of the ideal number of parents per well. Between 2 and 12 the number of obtained progeny is linear. Wild type strain is myo-2::GFP. bmk-1(ok391); myo-2::GFP is the mutant strain. (a, bottom) RFratio calculation and distribution of worms treated with an empty RNAi vector. Error bars represent SEM of three biological replicates, each containing two technical replicates. (b) Primary screen results. RFratio distribution of screen controls and library RNAi vectors. Dashed lines represent the thresholds for the definition of ‘enhancers’ (<0.5) and ‘suppressors’ (>1.5). Percentages represent the total number of negative (grey) and positive (orange) controls within each cut-off range. Total number of library RNAi vectors in each category is also represented by percentages (green). (c) Secondary screen results. RFratio distribution of each control or library RNAi vector across three biological replicates. Dashed line indicates the threshold value below which we considered the RNAi to ‘enhance’ bmk-1(ok391). Percentages represent the total number of negative controls (empty vector, hil-5 dsRNA, in dark grey), positive controls (orange) and library RNAi vectors (green) in each category. (d) Venn diagram showing the common and unique hits found within the biological replicates. 38 targeting sequences classify as ‘enhancers’ in at least two out of the three replicates.
Figure 3RNAi screen validation.
(a) Embryonic lethality assay with the screen's ‘enhancers’. N2 (blue), wild type strain. SV1005 (red), bmk-1(ok391) deletion strain. RNAi for bmk-1 was used as a negative control. Error bars represent SEM of three technical replicates. Top graph shows embryonic lethality and below the corresponding reproductive fitness (expressed in number of live progeny per parent). (b) Embryonic lethality assay upon weak (0 mM IPTG) or strong (0.5 mM IPTG) depletion of screen ‘enhancers’. Bars represent averages of two technical replicates.